The use of external mesh reinforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins

Biomaterials

Volumn 35, Issue 9, 2014, Pages 2588-2599

  Longchamp, Alban ^a   Alonso, Florian ^a   Dubuis, Céline ^a   Allagnat, Florent ^a   Berard, Xavier ^b   Meda, Paolo ^c   Saucy, François ^a   Corpataux, Jean Marc ^a   Sebastien Deglise ^a   Haefliger, Jacques Antoine ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Caspase 3; External polyester mesh reinforcement; Intimal hyperplasia; MMPs; Shear stress; Vein graft

Indexed keywords

CELL DEATH; GRAFTING (CHEMICAL); MESH GENERATION; MUSCLE; POLYESTERS; REINFORCEMENT; SCAFFOLDS; SCAFFOLDS (BIOLOGY); SHEAR FLOW;

CASPASE-3; INTIMAL HYPERPLASIA; MESH REINFORCEMENT; MMPS; VEIN GRAFTS;

SHEAR STRESS;

CALPONIN; CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE B; HEME OXYGENASE 1; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR TYPE I; POLYESTER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; EXTERNAL MESH REINFORCEMENT; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; HYPERBARISM; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IMPLANT; MALE; MIDDLE AGED; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; SHEAR STRESS; SMOOTH MUSCLE FIBER; UPREGULATION; VASODILATATION; VERY ELDERLY; WESTERN BLOTTING;

CASPASE-3; EXTERNAL POLYESTER MESH REINFORCEMENT; INTIMAL HYPERPLASIA; MMPS; SHEAR STRESS; VEIN GRAFT;

AGED; AGED, 80 AND OVER; CASPASE 3; DOWN-REGULATION; EPHRIN-B2; FEMALE; HEME OXYGENASE (DECYCLIZING); HUMANS; HYPERPLASIA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE III; PERFUSION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRESSURE; RECEPTOR, EPHB4; SAPHENOUS VEIN; STRESS, MECHANICAL; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA; TUNICA INTIMA;

EID: 84895029750     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.041     Document Type: Article

References (44)

1. Osgood M.J., Hocking K.M., Voskresensky I.V., Li F.D., Komalavilas P., Cheung-Flynn J., et al. Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein. JVasc Surg 2013, [Epub ahead of print].
2. Owens C.D. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. JVasc Surg 2010, 51(3):736-746.
3. Davies M.G., Hagen P.O. Reprinted article "pathophysiology of vein graft failure: a review". Eur J Vasc Endovasc Surg 2011, 42(Suppl.1):S19-S29.
4. Mitra A.K., Gangahar D.M., Agrawal D.K. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol. 2006, 84(2):115-124.
5. Newby A.C., Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. JPathol 2000, 190(3):300-309.
6. Berceli S.A., Jiang Z., Klingman N.V., Schultz G.S., Ozaki C.K. Early differential MMP-2 and -9 dynamics during flow-induced arterial and vein graft adaptations. JSurg Res. 2006, 134(2):327-334.
7. Mountain D.J., Kirkpatrick S.S., Freeman M.B., Stevens S.L., Goldman M.H., Grandas O.H. Role of MT1-MMP in estrogen-mediated cellular processes of intimal hyperplasia. JSurg Res. 2012, 173(2):224-231.
8. Berard X., Deglise S., Alonso F., Saucy F., Meda P., Bordenave L., et al. Role of hemodynamic forces in the exvivo arterialization of human saphenous veins. JVasc Surg 2013, 57(5):1371-1382.
9. Morrow D., Sweeney C., Birney Y.A., Guha S., Collins N., Cummins P.M., et al. Biomechanical regulation of hedgehog signaling in vascular smooth muscle cells invitro and invivo. Am J Physiol Cell Physiol 2007, 292(1):C488-C496.
10. Dobrin P.B., Littooy F.N., Endean E.D. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 1989, 105(3):393-400.
11. Gusic R.J., Myung R., Petko M., Gaynor J.W., Gooch K.J. Shear stress and pressure modulate saphenous vein remodeling exvivo. JBiomech 2005, 38(9):1760-1769.
12. Gusic R.J., Petko M., Myung R., William Gaynor J., Gooch K.J. Mechanical properties of native and exvivo remodeled porcine saphenous veins. JBiomech 2005, 38(9):1770-1779.
13. Desai M., Mirzay-Razzaz J., von Delft D., Sarkar S., Hamilton G., Seifalian A.M. Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath. Vasc Med 2010, 15(4):287-297.
14. Vijayan V., Shukla N., Johnson J.L., Gadsdon P., Angelini G.D., Smith F.C., et al. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. JVasc Surg 2004, 40(5):1011-1019.
15. Jeremy J.Y., Gadsdon P., Shukla N., Vijayan V., Wyatt M., Newby A.C., et al. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials 2007, 28(6):895-908.
16. Zilla P., Human P., Wolf M., Lichtenberg W., Rafiee N., Bezuidenhout D., et al. Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates. JThorac Cardiovasc Surg 2008, 136(3):717-725.
17. Zilla P., Wolf M., Rafiee N., Moodley L., Bezuidenhout D., Black M., et al. Utilization of shape memory in external vein-graft meshes allows extreme diameter constriction for suppressing intimal hyperplasia: a non-human primate study. JVasc Surg 2009, 49(6):1532-1542.
18. Yeoman M.S., Reddy D., Bowles H.C., Bezuidenhout D., Zilla P., Franz T. Aconstitutive model for the warp-weft coupled non-linear behavior of knitted biomedical textiles. Biomaterials 2010, 31(32):8484-8493.
19. Zilla P., Moodley L., Wolf M.F., Bezuidenhout D., Sirry M.S., Rafiee N., et al. Knitted nitinol represents a new generation of constrictive external vein graft meshes. JVasc Surg 2011, 54(5):1439-1450.
20. Saucy F., Probst H., Alonso F., Berard X., Deglise S., Dunoyer-Geindre S., et al. Exvivo pulsatile perfusion of human saphenous veins induces intimal hyperplasia and increased levels of the plasminogen activator inhibitor 1. Eur Surg Res. 2010, 45(1):50-59.
21. Paroz A., Probst H., Saucy F., Mazzolai L., Rizzo E., Ris H.B., et al. Comparison of morphological and functional alterations of human saphenous veins after seven and fourteen days of exvivo perfusion. Eur Surg Res. 2004, 36(5):274-281.
22. Rey J., Probst H., Mazzolai L., Bosman F.T., Pusztaszeri M., Stergiopulos N., et al. Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus exvivo continuous perfusion of human saphenous vein. JSurg Res. 2004, 121(1):42-49.
23. Alonso F., Boittin F.X., Beny J.L., Haefliger J.A. Loss of connexin40 is associated with decreased endothelium-dependent relaxations and eNOS levels in the mouse aorta. Am J Physiol Heart Circ Physiol 2010, 299(5):H1365-H1373.
24. Alonso F., Krattinger N., Mazzolai L., Simon A., Waeber G., Meda P., et al. An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. Cardiovascular research 2010, 87(1):166-176.
25. Kudo F.A., Muto A., Maloney S.P., Pimiento J.M., Bergaya S., Fitzgerald T.N., et al. Venous identity is lost but arterial identity is not gained during vein graft adaptation. Arterioscler Thromb Vasc Biol. 2007, 27(7):1562-1571.
26. Sugimoto M., Yamanouchi D., Komori K. Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway. Surg Today 2009, 39(6):459-465.
27. Si Y., Ren J., Wang P., Rateri D.L., Daugherty A., Shi X.D., et al. Protein kinase C-delta mediates adventitial cell migration through regulation of monocyte chemoattractant protein-1 expression in a rat angioplasty model. Arterioscler Thromb Vasc Biol. 2012, 32(4):943-954.
28. Tasaki T., Yamada S., Guo X., Tanimoto A., Wang K.Y., Nabeshima A., et al. Apoptosis signal-regulating kinase 1 deficiency attenuates vascular injury-induced neointimal hyperplasia by suppressing apoptosis in smooth muscle cells. Am J Pathol 2013, 182(2):597-609.
29. Bechler S.L., Si Y., Yu Y., Ren J., Liu B., Lynn D.M. Reduction of intimal hyperplasia in injured rat arteries promoted by catheter balloons coated with polyelectrolyte multilayers that contain plasmid DNA encoding PKCdelta. Biomaterials 2013, 34(1):226-236.
30. Mano T., Luo Z., Malendowicz S.L., Evans T., Walsh K. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res 1999, 84(6):647-654.
31. Schachner T., Zou Y., Oberhuber A., Tzankov A., Mairinger T., Laufer G., et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 2004, 77(5):1580-1585.
32. Rzucidlo E.M., Martin K.A., Powell R.J. Regulation of vascular smooth muscle cell differentiation. JVasc Surg 2007, 45(Suppl.A):A25-A32.
33. Brown D.J., Rzucidlo E.M., Merenick B.L., Wagner R.J., Martin K.A., Powell R.J. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation. JVasc Surg 2005, 41(3):509-516.
34. Beck K., Wu B.J., Ni J., Santiago F.S., Malabanan K.P., Li C., et al. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia. Circ Res 2010, 107(12):1490-1497.
35. Cerrito M.G., Scagliarini A., Froio A., Liloia A., Busnelli M., Giovannoni R., et al. Heme oxygenase-1 inhibition prevents intimal hyperplasia enhancing nitric oxide-dependent apoptosis of vascular smooth muscle cells. Biol Pharm Bull. 2011, 34(8):1204-1214.
36. Freidja M.L., Toutain B., Caillon A., Desquiret V., Lambert D., Loufrani L., et al. Heme oxygenase 1 is differentially involved in blood flow-dependent arterial remodeling: role of inflammation, oxidative stress, and nitric oxide. Hypertension 2011, 58(2):225-231.
37. Turner N.A., Hall K.T., Ball S.G., Porter K.E. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis 2007, 193(1):36-43.
38. Fay W.P., Garg N., Sunkar M. Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol 2007, 27(6):1231-1237.
39. Melliere D., Desgrange P., Allaire E., Becquemin J.P. Long-term results of venous bypass for lower extremity arteries with selective short segment prosthetic reinforcement of varicose dilatations. Ann Vasc Surg 2007, 21(1):45-49.
40. Lundgren F. External support of a polytetrafluoroethylene graft improves patency for bypass to below-knee arteries. Ann Vasc Surg 2013, 27(8):1124-1133. Swedish External Support S.
41. Arvela E., Kauhanen P., Alback A., Lepantalo M., Neufang A., Adili F., et al. Initial experience with a new method of external polyester scaffolding for infrainguinal vein grafts. Eur J Vasc Endovasc Surg 2009, 38(4):456-462.
42. Carella G.S., Stilo F., Benedetto F., David A., Risitano D.C., Buemi M., et al. Femoro-distal bypass with varicose veins covered by prosthetic mesh. JSurg Res. 2011, 168(2):e189-194.
43. Murphy G.J., Newby A.C., Jeremy J.Y., Baumbach A., Angelini G.D. Arandomized trial of an external Dacron sheath for the prevention of vein graft disease: the extent study. JThorac Cardiovasc Surg 2007, 134(2):504-505.
44. Berard X., Brizzi V., Mayeux S., Sassoust G., Biscay D., Ducasse E., et al. Salvage treatment for venous aneurysm complicating vascular access arteriovenous fistula: use of an exoprosthesis to reinforce the vein after aneurysmorrhaphy. Eur J Vasc Endovasc Surg 2010, 40(1):100-106.